Creating a triple agonist was a major challenge
Sin embargo, existe una lnea de investigacin que ha generado debate, ya que el metabolismo de la L-carnitina por parte de la microbiota intestinal puede producir un compuesto llamado TMAO, que est asociado con un mayor riesgo de aterosclerosis y eventos cardiovasculares
Similarly, Survodutide follows pharmaceutical naming conventions for glucagon/GLP-1 dual agonists
It is important to note, however, that glucagon receptor activation can also increase hepatic glucose output
Conflict of interest FG received research support from Eli Lilly, LifeScan, and Takeda and served as a consultant and author for AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp and Dohme, Novo Nordisk, Roche Diabetes Care, and Sanofi